What's guidance for use of indirectTarget vs. BodySite?

XMLWordPrintableJSON

    • Type: Change Request
    • Resolution: Not Persuasive
    • Priority: Medium
    • FHIR Core (FHIR)
    • DSTU1 [deprecated]
    • Orders & Observations
    • STU
    • Observation
    • (profiles)
    • Hide

      IndirectTarget is preferrred used for identifying Fetus.

      Show
      IndirectTarget is preferrred used for identifying Fetus.
    • Eric Haas/Rob Hausam:9-0-4
    • Enhancement
    • Non-substantive

      Both could be used for "Fetus" - no significant difference between a tumor vs. a fetus in terms of connection to the Patient and need to track it as an identifiable entity over time. Given that "bodySite" is core, it should probably be the preferred solution.

            Assignee:
            Unassigned
            Reporter:
            Lloyd McKenzie
            Watchers:
            1 Start watching this issue

              Created:
              Updated:
              Resolved: